U.S. FDA approves experimental Alzheimer's drug

U.S. FDA approves experimental Alzheimer's drug

The U.S. Food and Drug Administration approved the Alzheimer's drug lecanemab developed by Eisai and Biogen for patients in the earliest stages of the mind-wasting disease.


Share:

Comments

Comentarios de Facebook